Skip to main content
Federal & State Lawfederalstatelaw.com
Home/Federal/Bills (Live)
HOUSE 1672119th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Maintaining Investments in New Innovation Act

Last Action
2/27/2025

Actions

  • 2025-02-27Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2025-02-27Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2025-02-27Introduced in House
  • 2025-02-27Introduced in House

CRS Summary

As of 2025-02-27 (00)

Maintaining Investments in New Innovation Act

This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)

Cosponsors (20)

  • John Joyce (R-PA)
  • Josh Gottheimer (D-NJ)
  • Claudia Tenney (R-NY)
  • Rudy Yakym (R-IN)
  • Joseph Morelle (D-NY)
  • Richard Hudson (R-NC)
  • Aaron Bean (R-FL)
  • Mariannette Miller-Meeks (R-IA)
  • Rick Allen (R-GA)
  • Beth Van Duyne (R-TX)
  • Scott Peters (D-CA)
  • Blake Moore (R-UT)
  • Dan Crenshaw (R-TX)
  • Neal Dunn (R-FL)
  • Kevin Hern (R-OK)
  • Mike Carey (R-OH)
  • Jefferson Shreve (R-IN)
  • August Pfluger (R-TX)
  • Pete Sessions (R-TX)
  • Addison McDowell (R-NC)

Subjects

  • Genetics
  • Medicare
  • Prescription drugs
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.